Long-term neurological sequelae of SARS-CoV-2 infection

We show that patients who survive the first 30 days of acute SARS-CoV-2 infection have an increased risk of various post-acute neurological disorders after 1 year compared with uninfected contemporaries. The burden of these sequelae (aspects of ‘long COVID’) has serious implications for patients as...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Research Briefing
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528864/
https://www.ncbi.nlm.nih.gov/pubmed/36192556
http://dx.doi.org/10.1038/s41591-022-02018-4
_version_ 1784801380492378112
collection PubMed
description We show that patients who survive the first 30 days of acute SARS-CoV-2 infection have an increased risk of various post-acute neurological disorders after 1 year compared with uninfected contemporaries. The burden of these sequelae (aspects of ‘long COVID’) has serious implications for patients as well as society.
format Online
Article
Text
id pubmed-9528864
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-95288642022-10-04 Long-term neurological sequelae of SARS-CoV-2 infection Nat Med Research Briefing We show that patients who survive the first 30 days of acute SARS-CoV-2 infection have an increased risk of various post-acute neurological disorders after 1 year compared with uninfected contemporaries. The burden of these sequelae (aspects of ‘long COVID’) has serious implications for patients as well as society. Nature Publishing Group US 2022-10-03 2022 /pmc/articles/PMC9528864/ /pubmed/36192556 http://dx.doi.org/10.1038/s41591-022-02018-4 Text en © This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Research Briefing
Long-term neurological sequelae of SARS-CoV-2 infection
title Long-term neurological sequelae of SARS-CoV-2 infection
title_full Long-term neurological sequelae of SARS-CoV-2 infection
title_fullStr Long-term neurological sequelae of SARS-CoV-2 infection
title_full_unstemmed Long-term neurological sequelae of SARS-CoV-2 infection
title_short Long-term neurological sequelae of SARS-CoV-2 infection
title_sort long-term neurological sequelae of sars-cov-2 infection
topic Research Briefing
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528864/
https://www.ncbi.nlm.nih.gov/pubmed/36192556
http://dx.doi.org/10.1038/s41591-022-02018-4

Ejemplares similares